Subscribe to Newsletter

Emma Walmsley

The Power List 2021 – Biopharmaceuticals

Chief Executive Officer at GlaxoSmithKline

Walmsley first joined GSK in 2010, initially working for the Consumer Healthcare, Europe, division. She became CEO in April 2017. The company missed a key internal profit goal in 2020 due to the impact of the pandemic, but still performed well. Recently, the company announced promising results from a phase III trial with Vir Biotechnology for a monoclonal antibody to treat COVID-19.

Part of the Power List 2021

Find out more

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products

Go to The Power List 2021

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine